Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03079713 · ClinicalTrials.gov registry record · NA
Handheld Vibrator Versus Topical Eye Drops as Anesthesia for Intravitreal Injections
A NA study of Pain Control During Intravitreal Injections, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT03079713: Completed NA study of Pain Control During Intravitreal Injections, sponsored by Wills Eye.
NCT03079713 is a NA study of Pain Control During Intravitreal Injections that has completed, run by Wills Eye. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03079713, a NA study of Pain Control During Intravitreal Injections, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
Intravitreal injections are an efficient method of delivering therapeutic levels of medications to the posterior segment of the eye. Prior to receiving an injection, there are various methods to provide ocular anesthesia. Vibration may have an anti-nociceptive effect by directly decreasing the sensitivity of peripheral nociceptors or by reducing signal transmission from peripheral nociceptors to the brain with activation of vibratory sensation pathways. The purpose of this study is to evaluate the use of a handheld fingertip vibrator compared to topical eye drops for pain control while performing intravitreal eye injections. A secondary objective of the study is to measure corneal and conjunctiva sensitivity with and without activation of the vibrator to the lower lid using a Luneau Cochet-Bonnet aesthesiometer.
Primary Outcome
Pain is assessed by Wong-Baker FACES Pain Rating Scale (score ranging from 0 to 10) immediately after the intravitreal injection
Conditions Studied
Interventions
- DEVICE Handheld vibrator triggered during intravitreal injection for wet ARMD
- DEVICE Normal eye esthesiometry with and without vibration
- DEVICE Handheld vibrator not triggered during intravitreal injection for wet ARMD
Study Locations (1)
Pennsylvania
- MidAtlantic Retina-Wills Eye Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2017-04-12 |
| Est. Completion | 2019-03-20 |
| Phase | NA |
What the finished NCT03079713 record still lists
NCT03079713 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Pain Control During Intravitreal Injections appearing as the primary indexed condition, and to 3 interventions - of which Handheld vibrator triggered during intravitreal injection for wet ARMD is the first listed.
NCT03079713 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03079713 about?
NCT03079713 is a clinical study titled "Handheld Vibrator Versus Topical Eye Drops as Anesthesia for Intravitreal Injections". Intravitreal injections are an efficient method of delivering therapeutic levels of medications to the posterior segment of the eye. Prior to receiving an injection, there are various methods to provide ocular anesthesia. Vibration may have an anti-nociceptive effect by directly decreasing the sensi...
What is the current status of trial NCT03079713?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2017-04-12. Estimated completion is 2019-03-20.
What conditions does trial NCT03079713 study?
This clinical trial studies the following conditions: Pain Control During Intravitreal Injections.
What interventions are being tested in trial NCT03079713?
The interventions under investigation include: Handheld vibrator triggered during intravitreal injection for wet ARMD (DEVICE), Normal eye esthesiometry with and without vibration (DEVICE), Handheld vibrator not triggered during intravitreal injection for wet ARMD (DEVICE).
Who is sponsoring clinical trial NCT03079713?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03079713 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03079713's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI